Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Burkhoff

Showing results (431-440 of 484) with videos related to

Pageof 49
Sort By:
European Journal of Heart Failure|November 27, 2021
Changes in inferior vena cava area represent a more sensitive metric than changes in filling pressures during experimental manipulation of intravascular volume and toneJuan B Ivey-Miranda, Friedrich Wetterling, Robert Gaul, et al.
The American Journal of Cardiology|October 27, 2019
Assessment of Predictors of Left Atrial Volume Response to a Transcatheter InterAtrial Shunt Device (from the REDUCE LAP-HF Trial)Thomas C Hanff, David M Kaye, Christopher S Hayward, et al.
American Heart Journal|November 15, 2025
Immediate changes in left ventricular cardiac mechanics following transcatheter aortic valve replacement for severe aortic stenosis - an in-vivo pressure-volume analysis studyAntoon J M van den Enden, Mark M P van den Dorpel, Giulio M Mondellini, et al.
Circulation|November 17, 2017
Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled TrialTed Feldman, Laura Mauri, Rami Kahwash, et al.
Journal of the American Heart Association|December 25, 2017
Pacemaker-Mediated Programmable Hypertension Control TherapyPetr Neuzil, Béla Merkely, Andrejs Erglis, et al.
Circulation. Heart Failure|September 17, 2019
Effect of Baseline Left Ventricular Ejection Fraction on 2-Year Outcomes After Transcatheter Aortic Valve Replacement: Analysis of the PARTNER 2 TrialsAriel Furer, Shmuel Chen, Bjorn Redfors, et al.
Lancet (London, England)|September 5, 2024
Temporary mechanical circulatory support in infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials with 6-month follow-upHolger Thiele, Jacob E Møller, Jose P S Henriques, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|February 19, 2024
Hemodynamic Optimization by Invasive Ramp Test in Patients Supported With HeartMate 3 Left Ventricular Assist DeviceGal Rubinstein, Cathrine M Moeller, Dor Lotan, et al.
European Journal of Heart Failure|April 4, 2024
Congestion patterns in severe tricuspid regurgitation and transcatheter treatment: Insights from a multicentre registryKarl-Philipp Rommel, Guillaume Bonnet, Vera Fortmeier, et al.
Circulation. Heart Failure|September 9, 2020
Invasive Hemodynamic Assessment and Classification of In-Hospital Mortality Risk Among Patients With Cardiogenic ShockKatherine L Thayer, Elric Zweck, Mohyee Ayouty, et al.
Pageof 49

Showing results (431-440 of 484) with videos related to

Sort By:
Pageof 49
European Journal of Heart Failure|November 27, 2021
Changes in inferior vena cava area represent a more sensitive metric than changes in filling pressures during experimental manipulation of intravascular volume and toneJuan B Ivey-Miranda, Friedrich Wetterling, Robert Gaul, et al.
The American Journal of Cardiology|October 27, 2019
Assessment of Predictors of Left Atrial Volume Response to a Transcatheter InterAtrial Shunt Device (from the REDUCE LAP-HF Trial)Thomas C Hanff, David M Kaye, Christopher S Hayward, et al.
American Heart Journal|November 15, 2025
Immediate changes in left ventricular cardiac mechanics following transcatheter aortic valve replacement for severe aortic stenosis - an in-vivo pressure-volume analysis studyAntoon J M van den Enden, Mark M P van den Dorpel, Giulio M Mondellini, et al.
Circulation|November 17, 2017
Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled TrialTed Feldman, Laura Mauri, Rami Kahwash, et al.
Journal of the American Heart Association|December 25, 2017
Pacemaker-Mediated Programmable Hypertension Control TherapyPetr Neuzil, Béla Merkely, Andrejs Erglis, et al.
Circulation. Heart Failure|September 17, 2019
Effect of Baseline Left Ventricular Ejection Fraction on 2-Year Outcomes After Transcatheter Aortic Valve Replacement: Analysis of the PARTNER 2 TrialsAriel Furer, Shmuel Chen, Bjorn Redfors, et al.
Lancet (London, England)|September 5, 2024
Temporary mechanical circulatory support in infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials with 6-month follow-upHolger Thiele, Jacob E Møller, Jose P S Henriques, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|February 19, 2024
Hemodynamic Optimization by Invasive Ramp Test in Patients Supported With HeartMate 3 Left Ventricular Assist DeviceGal Rubinstein, Cathrine M Moeller, Dor Lotan, et al.
European Journal of Heart Failure|April 4, 2024
Congestion patterns in severe tricuspid regurgitation and transcatheter treatment: Insights from a multicentre registryKarl-Philipp Rommel, Guillaume Bonnet, Vera Fortmeier, et al.
Circulation. Heart Failure|September 9, 2020
Invasive Hemodynamic Assessment and Classification of In-Hospital Mortality Risk Among Patients With Cardiogenic ShockKatherine L Thayer, Elric Zweck, Mohyee Ayouty, et al.
Pageof 49